Equillium Inc (EQ)
1.49
+0.02
(+1.36%)
USD |
NASDAQ |
May 31, 16:00
1.50
+0.01
(+0.67%)
After-Hours: 20:00
Equillium Cash and Short Term Investments (Quarterly): 32.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 32.28M |
December 31, 2023 | 40.87M |
September 30, 2023 | 46.31M |
June 30, 2023 | 48.38M |
March 31, 2023 | 61.99M |
December 31, 2022 | 71.02M |
September 30, 2022 | 44.52M |
June 30, 2022 | 57.56M |
March 31, 2022 | 68.82M |
December 31, 2021 | 80.71M |
September 30, 2021 | 90.69M |
June 30, 2021 | 97.64M |
Date | Value |
---|---|
March 31, 2021 | 104.08M |
December 31, 2020 | 82.16M |
September 30, 2020 | 90.54M |
June 30, 2020 | 42.61M |
March 31, 2020 | 47.68M |
December 31, 2019 | 53.14M |
September 30, 2019 | 62.24M |
June 30, 2019 | 56.94M |
March 31, 2019 | 61.61M |
December 31, 2018 | 65.91M |
September 30, 2018 | 4.982M |
June 30, 2018 | 6.626M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
32.28M
Minimum
Mar 2024
104.08M
Maximum
Mar 2021
64.01M
Average
59.78M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Janux Therapeutics Inc | 651.76M |
Mersana Therapeutics Inc | 183.15M |
Vera Therapeutics Inc | 403.66M |
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 10.01M |